☆ 4.8 Letter

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Related references

Note: Only part of the references are listed.
Article Immunology

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study

Priscilla Kim et al.

Summary: Infection with SARS-CoV-2 provides strong protection against reinfection with the Delta variant, and natural immunity from prior infection lasts for at least 13 months.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection
Article Multidisciplinary Sciences

Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections

Laith J. Abu-Raddad et al.

Summary: The viral loads of SARS-CoV-2 breakthrough infections and reinfections are generally lower than primary infections in unvaccinated individuals, indicating potentially lower infectiousness. COVID-19 vaccines not only protect against acquisition of infection but also appear to protect against transmission.

NATURE COMMUNICATIONS (2022)

Add to Collection
Letter Medicine, General & Internal

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant

Hiam Chemaitelly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study

Laith J. Abu-Raddad et al.

Summary: The novel SARS-CoV-2 variant B.1.1.7 (Alpha) can cause a significant epidemic wave when introduced into a naive population, but individuals with prior infections have strong immunity against reinfection with B.1.1.7.

PLOS MEDICINE (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.